Literature DB >> 30617946

The effects of trehalose glycolipid presentation on cytokine production by GM-CSF macrophages.

Bridget L Stocker1,2, Kristel Kodar3,4, Kanu Wahi3,4, Amy J Foster3,4, Jacquie L Harper3, Daiki Mori5, Sho Yamasaki5,6,7,8, Mattie S M Timmer9,10.   

Abstract

Trehalose glycolipids (TGLs) are promising vaccine adjuvants, however effects of glycolipid presentation in the in vitro evaluation, and ultimate selection, of lead vaccine adjuvants are often overlooked. To this end, we synthesised a variety of TGLs and determined how the physicochemical presentation of these lipids influenced the cytokine response by bone marrow derived macrophages (BMMs). The TGLs were presented to wild-type and Mincle-/- BMMs as micellar solutions, coated on plates, coated on beads or surfactant solubilised. Medium to long-chain TGLs, either coated on plates or surfactant solubilised, resulted in the highest BMM activation. Stimulation of BMMs with TGLs coated on beads led to a decreased cytokine response, as compared to TGLs alone. All the TGL responses were Mincle dependent, however the mode of presentation did not have the same effect for each individual TGL. This was most apparent for the C22 trehalose monoester, which showed reduced activity compared to its diester counterpart when presented on a plate, but similar activity to the diester when presented as micelles or on beads. Taken together, our findings support the use of several in vitro assays for selecting lead vaccine adjuvants, particularly if structural differences between the adjuvants are pronounced. Graphical abstract The mode of glycolipid presentation, such as micellar solutions, coated on plates, coated on beads or surfactant solubilised, influences the immune response to trehalose glycolipids.

Entities:  

Keywords:  Adjuvant; Macrophage; Mincle; Trehalose glycolipid

Mesh:

Substances:

Year:  2019        PMID: 30617946     DOI: 10.1007/s10719-018-09857-9

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  32 in total

1.  Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.

Authors:  Jesper Davidsen; Ida Rosenkrands; Dennis Christensen; Anil Vangala; Daniel Kirby; Yvonne Perrie; Else Marie Agger; Peter Andersen
Journal:  Biochim Biophys Acta       Date:  2005-11-14

2.  Cord factor (alpha,alpha-trehalose 6,6'-dimycolate) inhibits fusion between phospholipid vesicles.

Authors:  B J Spargo; L M Crowe; T Ioneda; B L Beaman; J H Crowe
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

3.  Studies on the toxic effects of quartz and a mycobacterial glycolipid, trehalose 6,6'-dimycolate.

Authors:  S S Syed; R L Hunter
Journal:  Ann Clin Lab Sci       Date:  1997 Sep-Oct       Impact factor: 1.256

Review 4.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction.

Authors:  Michael V Berridge; Patries M Herst; An S Tan
Journal:  Biotechnol Annu Rev       Date:  2005

5.  The role of surface in the biological activities of trehalose 6,6'-dimycolate. Surface properties and development of a model system.

Authors:  G S Retzinger; S C Meredith; K Takayama; R L Hunter; F J Kézdy
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

Review 6.  Trehalose glycolipids--synthesis and biological activities.

Authors:  Ashna A Khan; Bridget L Stocker; Mattie S M Timmer
Journal:  Carbohydr Res       Date:  2012-03-19       Impact factor: 2.104

7.  Stat6-Dependent Inhibition of Mincle Expression in Mouse and Human Antigen-Presenting Cells by the Th2 Cytokine IL-4.

Authors:  Thomas Hupfer; Judith Schick; Katrin Jozefowski; David Voehringer; Jenny Ostrop; Roland Lang
Journal:  Front Immunol       Date:  2016-10-14       Impact factor: 7.561

8.  Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation.

Authors:  Kerstin Werninghaus; Anna Babiak; Olaf Gross; Christoph Hölscher; Harald Dietrich; Else Marie Agger; Jörg Mages; Attila Mocsai; Hanne Schoenen; Katrin Finger; Falk Nimmerjahn; Gordon D Brown; Carsten Kirschning; Antje Heit; Peter Andersen; Hermann Wagner; Jürgen Ruland; Roland Lang
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

Review 9.  Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators.

Authors:  Elke S Bergmann-Leitner; Wolfgang W Leitner
Journal:  Vaccines (Basel)       Date:  2014-04-10

Review 10.  Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.

Authors:  Signe Tandrup Schmidt; Camilla Foged; Karen Smith Korsholm; Thomas Rades; Dennis Christensen
Journal:  Pharmaceutics       Date:  2016-03-10       Impact factor: 6.321

View more
  2 in total

1.  6,6'-Aryl trehalose analogs as potential Mincle ligands.

Authors:  Omer K Rasheed; George Ettenger; Cassandra Buhl; Robert Child; Shannon M Miller; Jay T Evans; Kendal T Ryter
Journal:  Bioorg Med Chem       Date:  2020-05-31       Impact factor: 3.641

2.  Design of Trehalose-Based Amide/Sulfonamide C-type Lectin Receptor Signaling Compounds.

Authors:  Omer K Rasheed; Cassandra Buhl; Jay T Evans; Kendal T Ryter
Journal:  ChemMedChem       Date:  2021-02-09       Impact factor: 3.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.